All treatments
Treatment
Vyvgart 1 000 mg solution for injection in pre-filled syringe clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
A double-blinded, randomized, placebo-controlled, multi-center trial of Efgartigimod in autoimmune dementia (EfgaDem)
This study is testing a new medicine, Vyvgart, for people with autoimmune dementia. It looks at whether the medicine can help improve memory and thinking, compared to a dummy treatment, over about a year.
For: Autoimmune dementiaGermany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease
This study is looking at a new medicine called Vyvgart for people with Thyroid Eye Disease. It aims to see if the medicine can help reduce bulging eyes and improve eye health, compared to a dummy medicine, over 24 weeks.
For: Thyroid Eye Disease (TED)Latvia · Austria · Italy